Clinical Study of Mobile Application- (App-) Based Family-Centered Care (FCC) Model Combined with Comprehensive Iron Removal Treatment in Children with Severe Beta Thalassemia

Background and Objective. Hemoglobinopathy is one of the most prevalent monogenic disorders in the world. Thalassemia is characterized by autosomal recessive deficiencies in hemoglobin production. The difficulties of iron overload caused by transfusions, which are the foundation of illness managemen...

Full description

Saved in:
Bibliographic Details
Published in:Applied bionics and biomechanics 2022, Vol.2022, p.1-7
Main Authors: Chen, Yuke, Huang, Xiuping, Lu, Qingmei, Lu, Jian, Huang, Xiaoxiao, Luo, Yanni, Huang, Fengxing
Format: Article
Language:English
Subjects:
Anemia
Applications programs
Blood diseases
Children
Children & youth
Chronic illnesses
Deferoxamine
Families & family life
Health services
Hemoglobin
Hemoglobinopathy
Hospitals
Intervention
Iron
Medical diagnosis
Medical personnel
Mobile computing
Nurses
Nursing
Parents & parenting
Patients
Pediatrics
Quality of life
Thalassemia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Objective. Hemoglobinopathy is one of the most prevalent monogenic disorders in the world. Thalassemia is characterized by autosomal recessive deficiencies in hemoglobin production. The difficulties of iron overload caused by transfusions, which are the foundation of illness management in the majority of patients with severe thalassemia, may further worsen the clinical features. There are numerous obstacles and restrictions to the currently accessible conventional therapy for thalassemia. The purpose of the study is to investigate the clinical impact of the family-centered care (FCC) model based on a mobile application (app) in conjunction with comprehensive iron removal therapy for children with severe beta thalassemia. Methods. A retrospective study was conducted on the clinical records of 148 children diagnosed with severe beta thalassemia who were admitted to our hospital between October 2018 and September 2021. The patients were separated into two groups, a control group and an intervention group, with 74 cases in each group, according to the various care approaches. The basic treatment regimen was given to all of the children: deferoxamine mesylate combined with deferiprone. During treatment, the control group received routine care, and the intervention group adopted the FCC model based on a mobile app. The quality of life scale for children and adolescents (QLSCA) score, the family assessment device (FAD) score, the exercise of self-care agency scale (ESCA) score, and the medication compliance scale score were compared between the two groups. Results. The QLSCA score, ESCA score, and medication compliance scale score of the intervention group were significantly higher than those of the control group and showed a significant difference (intergroup effect: F=198.400, 259.200, and 129.800, all P
ISSN:1176-2322
1754-2103
DOI:10.1155/2022/4658709